Latest News from EMD

This series spotlights some of the amazing labs in the Department of Microbial Diseases at the Yale School of Public Health. The research conducted by our EMD colleagues addresses some of the most urgent global health challenges. Here, Dr. Steven Schiff talks about the Schiff Lab and their impactful work in the field of global health.

During an interview on the Health & Veritas podcast, Akiko Iwasaki, PhD, discussed post-acute infection syndromes, like Long COVID, and what we’re learning about them.

Despite cuts in federal funding for global health research, Yale School of Public Health Associate Professor Amy Bei has continued her work with support from alternate funding sources.

YSPH epidemiologist Gregg Gonsalves comments on a new rule limiting federal loans for students in nursing and some other medical fields.

According to the World Health Organization (WHO), antimicrobial resistance (AMR) is one of the top global public health and development threats. In 2019, bacterial AMR was directly responsible for 1.27 million deaths and contributed to 4.95 million deaths worldwide. AMR is also rapidly expanding among fungal, viral, and parasitic pathogens.

Scholar-at-Risk Eman Salih says her time at YSPH has been defined by the expansion of ideas, partnerships, and hope.

YSPH alumna Anumita Bajpai, MPH ’20, (Epidemiology of Microbial Diseases), is applying the laboratory and leadership skills she learned at YSPH to improve global health.

A new Yale-led study offers evidence for more effective TB screening strategies that could improve detection and outcomes in high-risk populations.

PopHIVE, a new platform created by a Yale School of Public Health team in collaboration with Dr. Anne Zink and others, pulls data from many sources to give a national picture of infectious and chronic diseases.